These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 139855)

  • 41. Human serum sickness: a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure.
    Bielory L; Gascon P; Lawley TJ; Young NS; Frank MM
    Medicine (Baltimore); 1988 Jan; 67(1):40-57. PubMed ID: 3257288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complement component profiles in urticaria, dermatitis herpetiformis, and alopecia areata.
    Berrens L; Jankowski E; Jankowski-Berntsen I
    Br J Dermatol; 1976 Aug; 95(2):145-52. PubMed ID: 952750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
    Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
    Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenetic factors in utricaria in children. A clinico-experimental study.
    Bonifazi E; Meneghini CL; Ceci A
    Dermatologica; 1977; 154(2):65-72. PubMed ID: 852623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement components, complement activation, and acute phase response in systemic lupus erythematosus.
    Sturfelt G; Sjöholm AG
    Int Arch Allergy Appl Immunol; 1984; 75(1):75-83. PubMed ID: 6086533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C1-bypass complement-activation pathway in patients with chronic urticaria and angio-oedema.
    Ballow M; Ward GW; Gershwin ME; Day NK
    Lancet; 1975 Aug; 2(7928):248-50. PubMed ID: 49798
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum complement components in Henoch-Schönlein purpura.
    Garcia-Fuentes M; Martin A; Chantler C; Williams DG
    Arch Dis Child; 1978 May; 53(5):417-9. PubMed ID: 666358
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating immune complexes in syphilis.
    Sølling J; Sølling K; Jakobsen KU; From E
    Acta Derm Venereol; 1978; 58(3):263-7. PubMed ID: 78643
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum IgG antibodies to C1q in hypocomplementemic urticarial vasculitis syndrome.
    Wisnieski JJ; Naff GB
    Arthritis Rheum; 1989 Sep; 32(9):1119-27. PubMed ID: 2528353
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective clinical and immunologic analysis of patients with serum sickness.
    Lawley TJ; Bielory L; Gascon P; Yancey KB; Young NS; Frank MM
    N Engl J Med; 1984 Nov; 311(22):1407-13. PubMed ID: 6387492
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Morphological and immunological evidence of coagulopathy in renal complications of pregnancy.
    Seymour AE; Petrucco OM; Clarkson AR; Haynes WD; Lawrence JR; Jackson B; Thompson AJ; Thomson NM
    Perspect Nephrol Hypertens; 1976; 5():139-53. PubMed ID: 63937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).
    Lloyd W; Schur PH
    Medicine (Baltimore); 1981 May; 60(3):208-17. PubMed ID: 7231154
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The complement system in uremia.
    Jørgensen KA; Stoffersen E
    Scand J Urol Nephrol; 1980; 14(3):279-82. PubMed ID: 6908167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protease inhibitors in plasma of patients with chronic urticaria.
    Doeglas HM; Bleumink E
    Arch Dermatol; 1975 Aug; 111(8):979-85. PubMed ID: 60915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating immune complexes, complement activation kinetics and serum sickness following treatment with heterologous anti-snake venom globulin.
    Nielsen H; Sørensen H; Faber V; Svehag SE
    Scand J Immunol; 1978; 7(1):25-33. PubMed ID: 635471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Role of complement in hyaline membrane disease].
    Benatre A; Grangeponte MC; Laugier J
    Nouv Presse Med; 1976 Jul 3-10; 5(27):1697. PubMed ID: 60739
    [No Abstract]   [Full Text] [Related]  

  • 60. [The significance of serum concentration of C3 and C4 for the diagnosis, prognosis and treatment of SLE].
    Yasue T; Akutsu J; Shinjô H; Sasada K
    Nihon Hifuka Gakkai Zasshi; 1975 Dec; 85(14):875-83. PubMed ID: 1240511
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.